header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

Hip

THE EFFECT OF BEARING SURFACE AND HEAD SIZE ON THE SURVIVAL OF UNCEMENTED AND HYBRID TOTAL HIP ARTHROPLASTY: AN ANALYSIS OF DATA FROM THE NATIONAL JOINT REGISTRY OF ENGLAND, WALES, NORTHERN IRELAND, AND THE ISLE OF MAN

The British Hip Society (BHS) Annual Scientific Meeting, Newport, Wales, March 2020.



Abstract

Aim

To assess the effect of the bearing surface and head size on the survival of total hip replacements with modern bearing surface combinations.

Methods

We combined the NJR dataset with polyethylene manufacturing properties as supplied by the manufacturers to sub-divide polyethylene into conventional (PE) and highly crosslinked (XLPE). Cause specific and overall reasons for revisions were analysed using Kaplan-Meier and multi-variate Cox proportional hazard regression survival analyses. The bearing surface analysis was repeated in patients undergoing THR under the age of 55.

Results

A total of 337,786 primary THR cases were included with an associated 5,618 revisions. Head size was grouped in <= 28mm (group A), 32mm (group B) and >=36mm (group C). A Cox regression model adjusted for age, gender, bearing combination and stem fixation was used to provide Hazard Ratios (HR). With Group C as reference, revision for all causes in Group A had a HR 1.07 (95%CI 0.99, 1.15) and in Group B HR 0.92 (0.86, 0.98). In patients <55y of age, with MoP as reference, Hazard Ratio for MoXLPE was 0.77 (0.59, 1.01), CoC 0.64 (0.52, 0.78), CoXLPE 0.61 (0.47, 0.78), CoP 0.50 (0.36, 0.70) and CMoXLPE 0.47 (0.30, 0.76).

Conclusion

When combined with modern bearing combinations, the use of femoral heads of 36mm or larger was associated with a decreased cumulative incidence of revision for dislocation and an increased incidence of revision for aseptic loosening. In patients under the age of 55, CMoXLPE performed best at maximum follow up of 11 years.


Email: